Yes, absolutely agree Chianti. I don't like personal abuse on forums like this but I say anyone who claims to be unaffected by A1 is a fool, they just don't know. Or they just assume that "minor" problems they experience cannot be anything to do with A1, without knowing whether this is true or not.
The science is linking A1/BCM7 with more and more conditions. Some, like autism, tend to show up when young (and SIDS of course shows up even before life has really not even got going). Others like diabetes and ischaemic heart disease may take decades to show up but the damage started when young. Inflammation is now emerging as a result of BCM7 damage, and most people wouldn't know what it means (sounds nice and vague doesn't it?), but it's a key precursor of cancer in many parts of the body.
So watch it, you guys who are so sure you are not affected by A1. And be aware that any individual is likely to be A1-tolerant for certain periods of life and then ka-ching they lose their "immunity" for some reason, such as being put onto antibiotics which wreck the immune system, albeit temporarily.
I've been following A2 as an investor for well over a decade, and can see that we may be entering the era that the company's founders , scientist Corran McLachlan and financier Howard Paterson, foresaw. An era in which the rest of the global dairy industry would realise consumers everywhere (and therefore farmers and processors too) will have to switch to A2. I agree with Mark06, A2 has the potential to be a top world-changing company. Some instos will continue trying to play around with the SP for a while because they just haven't a clue what they are playing with.
It therefore also follows that we should be watching for signs of big players entering the market when they read the China trial results, either with possible takeover bids or bidding for a decent cornerstone holding. That could easily send the SP rocketing overnight. Reaction expressed in the Food Navigator article from the US was very interesting. Representatives of big dairy in US are not rejecting the China trial, they are being very cautious and saying it's a well-done study but they want to see the next trial of 600 subjects. The old knee-jerk reaction has stopped. They're interested and thinking, and no doubt nervous as to what their next step has to be. Beat us or join us? Well they can't beat us except by buying us. Personally I hope they'll join us. Not all of them, but some amenable partners. Glad I'm not a director of Freedom Foods.
Expand
(20min delay)